Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Drugmakers’ finance costs jump 47% amid high interest rates
1+ hour, 42+ min ago (951+ words) Nigerian pharmaceutical companies listed on the Nigerian Exchange recorded a 46.5 per cent increase in combined finance costs in the first quarter of 2026, as high interest rates and growing reliance on debt continued to squeeze profitability across the sector. For stock…...
7 Countries Competing to Be the Region’s Next Biomanufacturing Hub
8+ hour, 49+ min ago (1410+ words) 25 July 2026 | Saturday | Analysis One caveat before the table. This is not the APAC Bioeconomy Index, which is a separate benchmark with its own methodology and a different purpose. This is a siting-decision comparison written for people choosing where to put…...
Bain Capital to Acquire UK's Top Vitamin Brand Vitabiotics in USD 900 Million Deal
10+ hour, 9+ min ago (309+ words) New Delhi: Bain Capital has agreed to acquire Vitabiotics, the UK's leading vitamin company, including its UK business and the wider VB Group, which includes Meyer Organics in India and operations in Africa. While the deal value was not officially…...
Nova Biomedical Advances Integrated Cell Line Development Workflows: NanoCellect products are now part of Nova Biomedical
2+ hour, 32+ min ago (119+ words) WALTHAM, Mass., July 24, 2026 /PRNewswire/ — Nova Biomedical today announced a transaction involving certain assets of NanoCellect, a provider of microfluidic cell sorting technology. This expansion of Nova’s portfolio will accelerate cell line development timelines and improve clone selection outcomes, while establishing…...
Brainless humans? Backup bodies? Inside biotech's depraved new world
9+ hour, 9+ min ago (630+ words) Rumors fly amid new tech that would make Frankenstein blush. Social media's magicians spent decades perfecting the art of slicing human attention into advertising revenue. Is the next step on the corporate road map farming human tissue for spare parts?...
Nazata Bio: The Startup That Thrives on Pressure
11+ hour, 39+ min ago (1634+ words) Nazata Bio co-founder Tom McCartan was seeking a chief technology officer when he called former classmate Shane O’Neill to seek recommendations. At the time, O’Neill was preparing to return to Ireland from Japan, where he had worked in software for…...
India’s pharma M&A market hits four-year high on blockbuster deals
11+ hour, 13+ min ago (248+ words) The Pharma Letter - India’s pharma M&A market hits four-year high on blockbuster deals India’s mergers and acquisitions (M&A) market hit a four-year high in the April to June quarter, powered by a single blockbuster: Sun Pharmaceutical Industries' (BOM:…...
Amilabs CEO LeBrun: The Real Cost of a $1.2 Billion Seed Round Is Expectations, Not Dilution — BigGo Finance
17+ hour, 30+ min ago (412+ words) This is not a subtle academic distinction. It defines which technology can actually power a robot that operates safely in your kitchen. The current industry attempt to stuff LLMs into robotics — Vision-Language-Action models — is, in LeBrun’s blunt assessment, a temporary…...
AstraZeneca 'magic' faces rare test after trial failure, share slide - AOL
12+ hour, 37+ min ago (665+ words) (Corrects name of rare neurological disorder, to ATTRv-PN, in paragraph 9) LONDON, July 24 (Reuters) - AstraZeneca's long-time CEO Pascal Soriot has rarely put a foot wrong. The company's shares have more that quadrupled in price during his 14-year tenure, soaring above the…...
AMI Labs, Oratomic and Prime Intellect: Founder Lessons
14+ hour, 45+ min ago (738+ words) For deep-tech beginners, the main lesson from AMI Labs, Oratomic and Prime Intellect is not that every AI startup can now raise hundreds of millions of dollars. It is that investors are paying exceptional prices for a small set of…...